How long can you stay on hormone therapy?
Current guidelines no longer set an arbitrary cutoff for hormone therapy. Duration is decided one year at a time, weighing your symptoms against your personal risk profile.
There is no mandatory stop date for hormone therapy. Leading guidelines have replaced arbitrary time limits with an annual review, continuing estradiol and micronized progesterone as long as benefits outweigh risks for you. Duration is individualized with your clinician, not fixed by the calendar or your age.
Why did the old five-year rule go away?
For years, women were told to stop hormone therapy after about five years regardless of symptoms. That advice came from early interpretations of the Women's Health Initiative, whose average participant started treatment at age 63. Later analysis showed the risk picture is very different for women who begin near the onset of menopause. As a result, modern guidance replaced the blanket cutoff with a yearly conversation about whether to continue.
There is no general rule for stopping systemic hormone therapy. The decision to continue should be individualized and based on a woman's symptoms and the balance of benefits and risks, regardless of age.
What does your clinician weigh at each review?
At least once a year, you and your clinician revisit whether hormone therapy still earns its place. The review is a fresh look at the same balance you struck when you started — symptom burden on one side, your personal and family health history on the other.
- Whether your hot flashes, night sweats, sleep, or mood symptoms return when you taper or pause
- Your age and how many years it has been since menopause began
- Personal and family history of breast cancer, blood clots, stroke, and heart disease
- Your route of estrogen — transdermal estradiol patches or gel may carry a lower clot risk than oral tablets
- Bone health goals, since estrogen helps preserve bone density during the years of fastest loss
Can you stay on hormone therapy long term?
Many women use hormone therapy for a decade or longer when symptoms persist and their risk profile remains favorable. Vasomotor symptoms can last well into the 60s for some women, and stopping does not guarantee they will not return. Long-term use is reasonable when it is reviewed regularly and the benefits continue to outweigh the risks for you. Lower doses or a switch from oral tablets to a transdermal patch or gel are common ways to refine therapy over time.
What about stopping?
When you and your clinician decide to stop, there is no single correct method. Some women stop outright; others taper the dose gradually to ease the transition. Tapering does not reliably prevent symptoms from returning, but it lets you gauge how you feel at each step. If symptoms come back and remain bothersome, restarting is a legitimate option — staying on therapy is not a failure, and there is no prize for stopping early.
| Approach | What it involves | Best fit |
|---|---|---|
| Continue long term | Keep current dose, review yearly with your clinician | Symptoms persist and risk profile stays favorable |
| Taper gradually | Step the dose down over weeks to months | Want to gauge symptom return before stopping fully |
| Stop outright | End treatment at a chosen date | Clinician and patient agree benefits no longer outweigh risks |
| Restart after stopping | Resume therapy if symptoms return and bother you | Stopping did not go as hoped — not a failure, a reasonable option |
Compounded preparations such as Biest are sometimes chosen with a clinician, but the same duration principles apply, and they are not safer or more effective by virtue of being compounded. Whatever the formulation, the right length of treatment is the one that keeps benefits ahead of risks for you, reviewed each year.
Questions, answered
No. Guidelines no longer set a mandatory stop age or duration. Many women continue past 60 or 65 when symptoms persist and their personal risk profile stays favorable. The decision is reviewed with your clinician at least once a year rather than dictated by your birthday.
Explore the related treatments
If this is relevant to you, these are the treatments it most often connects to.
Hot flashes & night sweats
Hot flashes and night sweats are the most common — and most treatable — symptoms of menopause. Hormone therapy is the most effective treatment available.
See the treatmentMood & brain fog
Brain fog, irritability, and low mood are real, hormone-driven symptoms of the menopause transition — not personal failings.
See the treatmentMore from the blog
Estradiol patch vs gel vs pill: how to choose
All three deliver the same body-identical estradiol. The real decision is transdermal versus oral — a route choice with meaningful implications for clot risk and convenience.
7 min readMicronized progesterone: benefits, timing, and side effects
If you take estrogen and have a uterus, micronized progesterone protects the uterine lining. Taken at bedtime, it also tends to help with sleep.
7 min readHormone therapy side effects: what to expect and when to call
Early side effects are usually mild and fade as your body adjusts. Knowing which are normal — and which are warning signs — helps you stay on treatment safely.
8 min readFeel like yourself again.
Take the 3-minute assessment, then meet your clinician by video or phone. No obligation.